RxDoctor Payments Data

Bethany Dempsey, PA

Physician Assistant · Fort Worth, TXNPI 1497370381

Payments from drug & device makers

$1,476in general payments, 2019–2025

Across 85 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$269
  • AstraZeneca$186
  • Dexcom, Inc.$122
  • Amarin Pharma, Inc.$97
  • Lilly USA, LLC$92
  • Amgen$75
  • plus $635 from 19 others

What the payments were for

  • Food & beverage$1,476100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,476 in reported general payments places this provider in the 70th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$1,419
Medicare patients
16
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide17$16,072
AbrysvoRsv Vacc, Pref A And Pref B/Pf11$2,995
ShingrixVaricella-Zoster Ge/As01b/Pf11$1,993
Atorvastatin Calcium51$1,099
Rosuvastatin Calcium33$930
Albuterol Sulfate HfaAlbuterol Sulfate22$871
Lisinopril47$699
Losartan Potassium34$519
Metformin Hcl ErMetformin Hcl16$474
Pantoprazole Sodium29$419
Amlodipine Besylate30$290
Metoprolol Succinate15$273
Pravastatin Sodium13$252
Gabapentin18$243
Duloxetine Hcl13$241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$92$16,07217 claims
GSKShingrix$25$1,99311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →